Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Colorcon
AstraZeneca
UBS
Boehringer Ingelheim
US Army
Farmers Insurance
Deloitte
Cantor Fitzgerald
Accenture

Generated: February 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019680

« Back to Dashboard

NDA 019680 describes DEPAKOTE, which is a drug marketed by Abbvie and Abbott and is included in four NDAs. It is available from three suppliers. There are six patents protecting this drug and two Paragraph IV challenges. Additional details are available on the DEPAKOTE profile page.

The generic ingredient in DEPAKOTE is divalproex sodium. There are seventeen drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the divalproex sodium profile page.
Summary for 019680
Tradename:DEPAKOTE
Applicant:Abbvie
Ingredient:divalproex sodium
Patents:0
Therapeutic Class:Anticonvulsants
Antimigraine Agents
Bipolar Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 019680
Suppliers and Packaging for NDA: 019680
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DEPAKOTE divalproex sodium CAPSULE, DELAYED REL PELLETS;ORAL 019680 NDA AbbVie Inc. 0074-6114 N 0074-6114-11
DEPAKOTE divalproex sodium CAPSULE, DELAYED REL PELLETS;ORAL 019680 NDA AbbVie Inc. 0074-6114 N 0074-6114-13

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, DELAYED REL PELLETS;ORALStrengthEQ 125MG VALPROIC ACID
Approval Date:Sep 12, 1989TE:ABRLD:Yes

Expired US Patents for NDA 019680

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie DEPAKOTE divalproex sodium CAPSULE, DELAYED REL PELLETS;ORAL 019680-001 Sep 12, 1989 ➤ Try a Free Trial ➤ Try a Free Trial
Abbvie DEPAKOTE divalproex sodium CAPSULE, DELAYED REL PELLETS;ORAL 019680-001 Sep 12, 1989 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
McKesson
Daiichi Sankyo
Express Scripts
UBS
Medtronic
Cerilliant
Johnson and Johnson
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot